Dias V M A, Campos A P C B, Chagas A J, Silva R M
Department of Pediatrics, Minas Gerais Federal University, Belo Horizonte, Brazil.
J Pediatr Endocrinol Metab. 2010 Aug;23(8):815-26. doi: 10.1515/jpem.2010.131.
The etiology of congenital hypothyroidism (CH) is important in determining its severity, prognosis, genetic counseling and clinical management.
investigate the causes of CH and their severity using serum levels of FreeT4 and TSH.
243 neonates with CH (61% were girls) diagnosed by the Neonatal Screening Program of Minas Gerais between 1996 and 2003. The thyroid function was assessed through serum FreeT4 and TSH by chemilumiscence. CH etiology was evaluated by ultrasonography, scintigraphy, potassium perchlorate discharge test and serum thyroglobulin levels.
Out of 243 patients, dysgenesis was found in 114 (47%): 3.3% had athyreosis; 0.4% eutopic dysgenetic gland due to maternal use of 131I; 22% ectopic glands (8.6% an isolated ectopic gland and 13% also an eutopic dysgenetic thyroid); 9% eutopic dysgenesis, 8.6% hypoplasia and 3.7% hemiagenesis. Thyroid in situ was found in 129 (52%): 23.5% had iodide organification defect; 3.7% thyroglobulin synthesis defect; 6.2% other 0.4% dyshomonogenesis; iodide transport defect; 1.2% transient CH and 18% a normal gland. Patients with dysgenesis had a more severe CH than those with thyroid in situ (TSH 248.08 vs. 18.17 microIU/mL and FT4 0.32 vs. 0.95 ng/dL, p < 0.001).
Some cases had more complex dysgenesis, presenting ectopia associated to a dysgenetic eutopic gland. The ultrasound was the best tool to detect the dysgenetic tissue, but the scintigraphy was the most effective in identifying the functioning tissue. The thyroid hormone synthesis defects were found more frequently than expected, but in some cases they could not be defined.
先天性甲状腺功能减退症(CH)的病因对于确定其严重程度、预后、遗传咨询及临床管理至关重要。
利用游离甲状腺素(FreeT4)和促甲状腺激素(TSH)血清水平研究CH的病因及其严重程度。
243例CH新生儿(61%为女孩),于1996年至2003年间由米纳斯吉拉斯州新生儿筛查项目诊断。通过化学发光法检测血清FreeT4和TSH评估甲状腺功能。通过超声、闪烁扫描、高氯酸钾释放试验及血清甲状腺球蛋白水平评估CH病因。
243例患者中,114例(47%)存在甲状腺发育不全:3.3%为无甲状腺;0.4%为由于母亲使用131I导致的正常位置发育不全腺体;22%为异位腺体(8.6%为孤立异位腺体,13%还伴有正常位置发育不全甲状腺);9%为正常位置发育不全,8.6%为发育不全,3.7%为半侧发育不全。129例(52%)甲状腺位置正常:23.5%存在碘有机化缺陷;3.7%存在甲状腺球蛋白合成缺陷;6.2%为其他0.4%为激素合成异常;碘转运缺陷;1.2%为暂时性CH,18%为甲状腺正常。甲状腺发育不全患者的CH比甲状腺位置正常患者更严重(TSH分别为248.08与18.17微国际单位/毫升,FT4分别为0.32与0.95纳克/分升,p<0.001)。
部分病例存在更复杂的发育不全,表现为异位与发育不全的正常位置腺体相关。超声是检测发育不全组织的最佳工具,但闪烁扫描在识别功能组织方面最有效。甲状腺激素合成缺陷的发现比预期更频繁,但在某些情况下无法明确。